Top Markets
#1 MowCat MowCat +281.14%
#2 龙虾 (Lobster) 龙虾 (Lobster) +84.41%
#3 Magma Finance Magma Finance +33.21%
#4 DeXe DeXe +26.70%
#5 Cortex Cortex +26.10%
#6 Akedo Akedo +24.36%
#7 SIXSEVEN SIXSEVEN +18.74%
#8 Pons Pons +15.44%
#9 OpenEden OpenEden +15.04%
#10 SODAX SODAX +14.18%
Coin of the day
MowCat MowCat
Settings
Language
ENGLISH
Currency
USD
Theme
Seaport Therapeutics, Inc. Common Stock Seaport Therapeutics, Inc. Common Stock

Seaport Therapeutics, Inc. Common Stock

SPTX
Rank in Stocks #8196
Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise... Seaport Therapeutics, Inc. is a developing biopharmaceutical enterprise currently undergoing clinical trials, focused on creating groundbreaking treatments for neuropsychiatric conditions. The company is primarily engaged in tackling disorders like depression and anxiety, utilizing its unique Glyph technology. This exclusive platform is engineered to allow for oral administration of drugs, circumventing initial metabolic processing in the liver, and thereby reducing the risk of liver enzyme elevations, hepatotoxicity, and other potential adverse reactions. Every therapeutic agent in their pipeline incorporates this advanced platform, with all research and development efforts exclusively dedicated to neuropsychiatric applications. Founded in 2024 and situated in Boston, Massachusetts, the company connects with medical professionals and influential experts across the healthcare and neuropsychiatric sectors.
Share Price
$24.77
Market Cap
$1.33B
Change (1 day)
-5.64%
Change (1 year)
-
Country
US
Trade Seaport Therapeutics, Inc. Common Stock (SPTX)

Category

Healthcare
Operating Margin for Seaport Therapeutics, Inc. Common Stock (SPTX)
Operating Margin as of 2026 TTM: 0.00%
According to Seaport Therapeutics, Inc. Common Stock latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for Seaport Therapeutics, Inc. Common Stock from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
38.59% -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
28.81% -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
25.72% -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
-149.01% -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.